Dynamic Light Scattering Analysis for the Determination of the Particle Size of Iron-Carbohydrate Complexes.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
07 07 2023
Historique:
medline: 25 7 2023
pubmed: 24 7 2023
entrez: 24 7 2023
Statut: epublish

Résumé

Intravenously administered iron-carbohydrate nanoparticle complexes are widely used to treat iron deficiency. This class includes several structurally heterogeneous nanoparticle complexes, which exhibit varying sensitivity to the conditions required for the methodologies available to physicochemically characterize these agents. Currently, the critical quality attributes of iron-carbohydrate complexes have not been fully established. Dynamic light scattering (DLS) has emerged as a fundamental method to determine intact particle size and distribution. However, challenges still remain regarding the standardization of methodologies across laboratories, specific modifications required for individual iron-carbohydrate products, and how the size distribution can be best described. Importantly, the diluent and serial dilutions used must be standardized. The wide variance in approaches for sample preparation and data reporting limit the use of DLS for the comparison of iron-carbohydrate agents. Herein, we detail a robust and easily reproducible protocol to measure the size and size distribution of the iron-carbohydrate complex, iron sucrose, using the Z-average and polydispersity index.

Identifiants

pubmed: 37486118
doi: 10.3791/63820
doi:

Substances chimiques

Ferric Oxide, Saccharated FZ7NYF5N8L
Iron E1UOL152H7

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Michael Burgert (M)

Vifor Pharma Group, Vifor Pharma Management Ltd.

Cintia Baptista Marques (CB)

Section of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva.

Gerrit Borchard (G)

Section of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva.

Erik Philipp (E)

Vifor Pharma Group, Vifor Pharma Management Ltd.

Maria Wilhelm (M)

Vifor Pharma Group, Vifor Pharma Management Ltd.

Amy Alston (A)

Vifor Pharma Group, Vifor Pharma Management Ltd; amy.barton@viforpharma.com.

Reinaldo Digigow (R)

Vifor Pharma Group, Vifor Pharma Management Ltd.

Articles similaires

Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis
Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Classifications MeSH